Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
12/2012
12/27/2012WO2012116274A3 Genetically modified animals and methods for making the same
12/27/2012WO2012108630A3 Sbta gene derived from synechocystis sp. pcc6803 and use thereof
12/27/2012WO2012095548A9 Dream inhibitors for treating neurodegenerative diseases
12/27/2012WO2012094586A3 Synthetic non-covalently self-assembling bipartite prna chimeras
12/27/2012WO2012092544A3 Nucleic acid molecules that confer resistance to coleopteran pests
12/27/2012WO2012089349A3 Novel polyketide compounds and methods of making same
12/27/2012WO2012085936A4 Recombinant respiratory syncytial virus plasmids and vaccines
12/27/2012WO2012058642A3 Use of sam68 for modulating signaling through the tnf receptor
12/27/2012WO2012058303A3 Rapid salmonella serotyping assay
12/27/2012WO2012050919A3 Chimeric spider silk and uses thereof
12/27/2012WO2012036437A9 Immunogenic peptide and composition having the peptide for preventing or treating hpv-related disease
12/27/2012WO2012012531A9 Compositions and methods featuring il-6 and il-21 antagonists
12/27/2012WO2011153440A9 Transposon mutagenesis system and methods of use
12/27/2012WO2006003215A9 Targeted transgenesis of short hairpin rna expression cassettes using recombinase mediated cassette exchange
12/27/2012US20120331588 Polypeptides Having Endoglucanase Activity And Polynucleotides Encoding Same
12/27/2012US20120331586 Plants having enhanced yield - related traits and a method for making the same
12/27/2012US20120331585 Plants having enhanced yield-related traits and a method for making the same
12/27/2012US20120331584 Plants having enhanced yield-related traits and a method for making the same
12/27/2012US20120331583 Modulating plant oil levels
12/27/2012US20120331581 Polynucleotides and polypeptides involved in post-transcriptional gene silencing
12/27/2012US20120331580 Mutant hydroxyphenylpyruvate dioxygenase polypeptides and methods of use
12/27/2012US20120331579 Transgenic plant male sterility
12/27/2012US20120331578 Method for Producing Recombinant Glycoproteins Having Beta1,2-Bound Xylose Residues
12/27/2012US20120331575 Transgenic non-human animals
12/27/2012US20120331574 Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereof
12/27/2012US20120329997 Antibodies against human csf-1r and uses thereof
12/27/2012US20120329992 Spider silk proteins and methods for producing spider silk proteins
12/27/2012US20120329990 B7-related nucleic acids and polypeptides useful for immunomodulation
12/27/2012US20120329857 Short Hairpin RNAs for Inhibition of Gene Expression
12/27/2012US20120329856 Methods And Compositions For Reducing Viral Genome Amounts In A Target Cell
12/27/2012US20120329855 Treatment of hepatocyte growth factor (hgf) related diseases by inhibition of natural antisense transcript to hgf
12/27/2012US20120329721 Means for preventing and treating cellular death and their biological applications
12/27/2012US20120329710 Methods of Inducing Regulated Pancreatic Hormone Production in Non-Pancreatic Islet Tissues
12/27/2012US20120329706 Hepatitis b virus pre-s1 derived synthetic polypeptides and uses thereof
12/27/2012US20120329679 Eukaryotic cell display systems
12/27/2012US20120329674 Methods for large scale functional evaluation of nucleotide sequences in plants
12/27/2012US20120329671 Methods of identifying obm modulators
12/27/2012US20120329663 14-3-3 sigma as a Biomarker of Basal Cancer
12/27/2012US20120329660 Methods and compositions for sorting and/or determining organisms
12/27/2012US20120329654 Corn event pv-zmgt32(nk603) and compositions and methods for detection thereof
12/27/2012US20120329160 Increased oil content by increasing yap1 transcription factor activity in oleaginous yeasts
12/27/2012US20120329159 Down-Regulation Of Gene Expression Using Artificial MicroRNAs
12/27/2012US20120329150 Methods and compositions for expressing negative-sense viral rna in canine cells
12/27/2012US20120329149 Humanized antibody
12/27/2012US20120329136 Methods and compositions for the production of recombinant virus vectors
12/27/2012US20120329126 Hybrid polymerases having the ability to produce long amplicons
12/27/2012US20120329115 Chromosomal dna integration method
12/27/2012US20120329114 Xylose utilizing zymomonas mobilis with improved ethanol production in biomass hydrolysate medium
12/27/2012US20120329108 Transaminase Biocatalysts
12/27/2012US20120329104 Modified microorganism having enhanced xylose utilization
12/27/2012US20120329103 Plant wall degradative compounds and systems
12/27/2012US20120329101 Polypeptides having cellobiohydrolase activity and polynucleotides encoding same
12/27/2012US20120329097 Nucleic acid amplification
12/27/2012US20120329094 Anti-CD22 Antibodies And Immunoconjugates and Methods of Use
12/27/2012US20120329093 Polynucleotides encoding antibodies that bind both il-17a and il-17f
12/27/2012US20120329091 Recombinant protein production in heterologous systems
12/27/2012US20120329090 Methods for Producing Heterologous Polypeptides in Thiol-Disulfide Oxidoreductase-Deficient Bacterial Mutant Cells
12/27/2012US20120329078 Method of diagnosing cancer using g-csf protein having a deletion of an amino acid sequence corresponding to exon 3 as a diagnostic cancer marker
12/27/2012US20120329067 Methods of Generating Zinc Finger Nucleases Having Altered Activity
12/27/2012US20120329065 Use of novel cytokine receptors as biomarkers and therapeutic targets in human cancer
12/27/2012US20120329063 Novel means for the diagnosis and therapy of ctcl
12/27/2012US20120329056 Methods of evaluating relapse risk of acute myeloid leukemia using nucleic acids or fragments encoding flt3 kinase
12/27/2012US20120329052 Identification of a dna variant associated with adult type hypolactasia
12/27/2012US20120329049 Bcr-abl1 splice variants and uses thereof
12/27/2012US20120328684 Citrobacter freundii antibacterial agents and their use
12/27/2012US20120328668 Modified sirna molecules and uses thereof
12/27/2012US20120328658 Compositions and methods for vaccinating against hsv-2
12/27/2012US20120328657 Compositions and methods for vaccinating against hsv-2
12/27/2012US20120328653 Modified immunization vectors
12/27/2012US20120328651 Chimpanzee adenovirus vaccine carriers
12/27/2012US20120328650 Modified vaccinia ankara virus variant
12/27/2012US20120328642 Botulinum neurotoxin antigenic compositions and methods
12/27/2012US20120328641 Conformationally stabilized hiv envelope immunogens
12/27/2012US20120328638 Mybl2 peptides and vaccines containing the same
12/27/2012US20120328636 Kdr peptides and vaccines comprising the same
12/27/2012US20120328625 Targeted binding agents directed to sonic hedgehog homolog and uses thereof
12/27/2012US20120328623 ANTI-erbB3 ANTIBODY
12/27/2012US20120328622 Novel compounds
12/27/2012US20120328620 Epidermalgrowth factor receptor mutations
12/27/2012US20120328619 Trispecific Therapeutics Against Acute Myeloid Leukaemia
12/27/2012US20120328616 Human antigen binding proteins that bind to a complex comprising beta-klotho and an fgf receptor
12/27/2012US20120328613 Humanized anti-factor d antibodies and uses thereof
12/27/2012US20120328612 Anti-flt3 antibodies and methods of using the same
12/27/2012US20120328590 Anti-cancer therapeutic strategy to overcome cancer resistance and to enable tailoring treatment to patients
12/27/2012US20120328584 Biological Pacemaker
12/27/2012US20120328576 Defined dose therapeutic phage
12/27/2012US20120328575 Modified Oncolytic Viruses
12/27/2012US20120328559 Compositions and Methods for Treating Inflammatory Lung Disease
12/27/2012US20120328517 Kallikrein-binding "kunitz domain" proteins and analogues thereof
12/27/2012US20120328511 Novel Antigen Binding Proteins
12/27/2012DE102004031579B4 Peptide zur Inhibition der Interaktion von Proteinkinase A und Proteinkinase A-Ankerproteinen, diese umfassendes Nukleinsäuremolekül, Vektor, Wirtszelle, gegen diese gerichtetes Erkennungsmolekül, diese enthaltende pharmazeutische Zusammensetzung, diese enthaltender Kit und deren Verwendung Peptides to inhibit the interaction of protein kinase A and protein kinase A anchoring proteins, these nucleic acid molecule comprising, vector, host cell recognition molecule directed against these, these containing pharmaceutical composition containing them and their use kit
12/27/2012CA2875484A1 Influenza virus mutants and uses therefor
12/27/2012CA2842742A1 Phenocopy model of disease
12/27/2012CA2840522A1 Molecular diagnostic panel of eosinophilic gastrointestinal disorders
12/27/2012CA2840461A1 Anti-erbb3 antibody
12/27/2012CA2840113A1 An il-15 and il-15r.alpha. sushi domain based immunocytokines
12/27/2012CA2839995A1 Computationally optimized broadly reactive antigens for h1n1 influenza
12/27/2012CA2839988A1 Microfluidic photoporation
12/27/2012CA2839917A1 Compositions, methods and uses for alpha-1 antitrypsin fusion molecules
12/27/2012CA2839896A1 Assays and methods for determining activity of a therapeutic agent in a subject
1 ... 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 430 431 432 433 ... 4023